54
Views
2
CrossRef citations to date
0
Altmetric
Original Research

PRPH2 Activates Hippo Signalling and Suppresses the Invasion and Anoikis Inhibition of Laryngeal Cancer

, , , , , & show all
Pages 10107-10115 | Published online: 02 Dec 2019

References

  • Chu EA, Kim YJ. Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am. 2008;41:673–695. doi:10.1016/j4tc.2008.01.01618570953
  • Fu Q, Liu P, Sun X, et al. Ribonucleic acid interference knockdown of IL-6 enhances the efficacy of cisplatin in laryngeal cancer stem cells by down-regulating the IL-6/STAT3/HIF1 pathway. Cancer Cell Int. 2017;17:79. doi:10.1186/s12935-017-0448-028878571
  • Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 2006;127:679–695. doi:10.1016/j.cell.2006.11.00117110329
  • Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 2003;3:453–458. doi:10.1038/nrc109812778135
  • Wang J, Ge W, Wang Y, et al. MiR-613 suppressed the laryngeal squamous cell carcinoma progression through regulating PDK1. J Cell Biochem. 2017. doi:10.1002/jcb.26468
  • Rothman KJ, Cann CI, Flanders D, et al. Epidemiology of laryngeal cancer. Epidemiol Rev. 1980;2:195–209. doi:10.1093/oxfordjournals.epirev.a0362237000536
  • Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30. doi:10.3322/caac.v63.123335087
  • Tamaki A, Miles BA, Lango M, et al. AHNS series: do you know your guidelines? Review of current knowledge on laryngeal cancer. Head Neck. 2017. doi:10.1002/hed.24862
  • Han Q, Lin X, Zhang X, et al. WWC3 regulates the Wnt and hippo pathways via dishevelled proteins and large tumour suppressor 1, to suppress lung cancer invasion and metastasis. J Pathol. 2017;242:435–447. doi:10.1002/path.2017.242.issue-428543074
  • Tong R, Yang B, Xiao H, et al. KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating hippo signaling. Oncotarget. 2017;8:37717–37729. doi:10.18632/oncotarget.v8i2328465479
  • Varzavand A, Hacker W, Ma D, et al. α3β1 integrin suppresses prostate cancer metastasis via regulation of the hippo pathway. Cancer Res. 2016;76:6577–6587. doi:10.1158/0008-5472.CAN-16-148327680681
  • van Rensburg HJJ, Yang X. The roles of the hippo pathway in cancer metastasis. Cell Signal. 2016;28:1761–1772. doi:10.1016/j.cellsig.2016.08.00427519476
  • Juan WC, Hong W. Targeting the hippo signaling pathway for tissue regeneration and cancer therapy. Genes. 2016;7:55. doi:10.3390/genes7090055
  • Démant P, Iványi D, van Nie R. The map position of the rds gene on the 17th chromosome of the mouse. Tissue Antigens. 1979;13:53–55. doi:10.1111/j.1399-0039.1979.tb01136.x419532
  • Stuck MW, Conley SM, Naash MI. Retinal degeneration slow (RDS) glycosylation plays a role in cone function and in the regulation of RDS·ROM-1 protein complex formation. J Biol Chem. 2015;290:27901–27913. doi:10.1074/jbc.M115.68369826420485
  • Zulliger R, Conley SM, Mwoyosvi ML, et al. Oligomerization of Prph2 and Rom1 is essential for photoreceptor outer segment formation. Hum Mol Genet. 2018;27:3507–3518. doi:10.1093/hmg/ddy24029961824
  • Conley SM, Stuck MW, Watson JN, et al. Prph2 initiates outer segment morphogenesis but maturation requires Prph2/Rom1 oligomerization. Hum Mol Genet. 2019;28:459–475. doi:10.1093/hmg/ddy35930307502
  • Stuck MW, Conley SM, Naash MI. PRPH2/RDS and ROM-1: historical context, current views and future considerations. Prog Retin Eye Res. 2016;52:47–63. doi:10.1016/j.preteyeres.2015.12.00226773759
  • Chakraborty D, Conley SM, Al-Ubaidi MR, et al. Initiation of rod outer segment disc formation requires RDS. PLoS One. 2014;9:e98939. doi:10.1371/journal.pone.009893924897172
  • Zhang Z, Chometon G, Wen T, et al. Migration of epithelial cells on laminins: RhoA antagonizes directionally persistent migration. Eur J Cell Biol. 2011;90:1–12. doi:10.1016/j.ejcb.2010.09.00520971525
  • Schmidt-Erfurth U, Hasan T. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol. 2000;45:195–214. doi:10.1016/S0039-6257(00)00158-211094244
  • Zhang Z, Lin Z, Zhou Z, et al. Structure-based design and synthesis of potent cyclic peptides inhibiting the YAP-TEAD protein-protein interaction. ACS Med Chem Lett. 2014;5:993–998. doi:10.1021/ml500160m25221655
  • Salcedo Allende MT, Zeron-Medina J, Hernandez J, et al. Overexpression of yes associated protein 1, an independent prognostic marker in patients with pancreatic ductal adenocarcinoma, correlated with liver metastasis and poor prognosis. Pancreas. 2017;46:913–920. doi:10.1097/MPA.000000000000086728697132
  • Qiao Y, Chen J, Lim YB, et al. YAP regulates actin dynamics through ARHGAP29 and promotes metastasis. Cell Rep. 2017;19:1495–1502. doi:10.1016/j.celrep.2017.04.07528538170
  • Li C, Wang S, Xing Z, et al. A ROR1-HER3-lncRNA signalling axis modulates the hippo-YAP pathway to regulate bone metastasis. Nat Cell Biol. 2017;19:106–119. doi:10.1038/ncb346428114269
  • Nokin MJ, Durieux F, Peixoto P, et al. Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP-mediated tumor growth and metastasis. Elife. 2016;5:e19375. doi:10.7554/eLife.1937527759563